Multiple chemical sensitivity: A review of the theoretical and research literature

Neuropsychology Review

Volumn 10, Issue 4, 2000, Pages 183-211

  Labarge, A S ^a   McCaffrey, R J ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Multiple chemical sensitivity

Indexed keywords

ALEXITHYMIA; COGNITION; DIFFERENTIAL DIAGNOSIS; HEME SYNTHESIS; MENTAL DISEASE; MULTIPLE CHEMICAL SENSITIVITY; NEUROPSYCHOLOGY; REVIEW; SYMPTOMATOLOGY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MULTIPLE CHEMICAL SENSITIVITY; NEUROPSYCHOLOGICAL TESTS; PSYCHOPHYSIOLOGY; RESEARCH;

EID: 0034536830     PISSN: 10407308     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026460726965     Document Type: Review

References (258)

1. Modelling anxiety disorders following chemical exposures
2. Is there evidence of an immunological basis for multiple chemical sensitivity?
3. Position statements: Controversial techniques
4. Position statement: Clinical ecology
5. Clinical ecology
6. Successful use of a selective serotonin reuptake inhibitor in a patient with multiple chemical sensitivities
7. Time-dependent sensitization in animals: A possible model of multiple chemical sensitivity in humans
8. Case definitions for multiple chemical sensitivity
9. Advancing the understanding of multiple chemical sensitivity
10. Intimidation of researchers by special-interest groups
11. 'Chemically sensitive' patients: Avoiding the pitfalls
12. Multiple chemical sensitivity: A respiratory disorder? Toxicology and Industrial Health
13. Neurogenic inflammation: With additional discussion of central and perceptual integration of nonneurogenic inflammation
14. Patients with chronic somatization: What can the psychiatrist offer?
15. Respiratory and psychiatric abnormalities in chronic symptomatic hyperventilation
16. The role of the psychological factors in the report of the building-related symptoms in sick building syndrome
17. Neuropsychiatric and biosocial mechanisms in multiple chemical sensitivity: An olfactory-limbic model
18. White paper: Neuropsychiatric aspects of sensitivity to low-level chemicals: A neural sensitization model
19. An olfactory-limbic model of multiple chemical sensitivity syndrome: Possible relationships to kindling and affective spectrum disorders
20. Serum neopterin and somatization in women with chemical intolerance, depressives, and normals
21. Testing the neural sensitization and kindling hypothesis for illness from low levels of environmental chemicals
22. Individual differences in neural sensitization and the role of context in illness from low-level environmental chemical exposures
23. Differential resting qEEG alpha patterns in women with environmental chemical intolerance, depressives, and normals
24. Time-dependent sensitization of heart rate and blood pressure over multiple laboratory sessions in elderly individuals with chemical odor intolerance
25. Systematic considerations in the area of multiple chemical sensitivity
26. Panic response to sodium lactate infusion in patients with multiple chemical sensitivity syndrome
27. Environmental illness and misdiagnosis: A growing problem
28. Iatrogenic (physician-induced) hypochondriasis: Four patient examples of 'chemical sensitivity'
29. Total environmental allergy: 20th century disease or deception?
30. Environmental illness: A controlled study of 26 subjects with '20th century disease'
31. Measures of distress in 26 'environmentally ill' subjects
32. MCS: Cooperation between toxicology and psychology may facilitate solutions of the problems: Commentary
33. Conditioning of physical symptoms after neurotoxic exposure
34. 'Allergic to everything': A medical subculture
35. Psychological factors contributing to somatoform diseases attributed to the workplace: The case of intoxication
36. Multiple chemical sensitivities and other 'environmental illness': A psychiatrist's view
37. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities
38. Sick building syndrome: A study of 4,373 office workers
39. Cognitive behaviour therapy in chronic fatigue syndromes
40. Clinical ecology - A critical appraisal
41. Psychoneuroimmunology
42. A review of mass psychogenic illness in work settings
43. Patients with multiple chemical sensitivities: Clinical diagnostic subsets among an occupational health clinic population
44. Clinical ecology
45. The diagnostic utility of lactate sensitivity in panic disorder
46. The worker with chemical sensitivities: An overview
47. Multiple chemical sensitivities: Development of public policy in the face of scientific uncertainty
48. The experience of the Yale occupational and environmental medicine clinics with multiple chemical sensitivities
49. Multiple chemical sensitivity syndrome: The wavering influence of the courts on public policy
50. Panic disorder precipitated by exposure to organic solvents in the workplace
51. The influence of cognitive bias on the perceived odor, irritation and health symptoms from chemical exposure
52. Environmental chemical exposures and disturbances of heme synthesis
53. Psychogenic origins of multiple chemical sensitivities syndrome: A critical review of the research literature
54. Multiple chemical sensitivity
55. The brief symptom inventory: An introductory report
56. The messenger under attack - Intimidation of researchers by special-interest groups
57. Neurocognitive functioning in chronic fatigue syndrome
58. Intimidation of researchers by special-interest groups
59. Olfaction and multiple chemical sensitivity
60. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities
61. Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test of olfactory function
62. Fatigue syndromes revisited: The possible role of porphyrins
63. Neurotoxic complaint base rates of personal injury claimants: Implications for neuropsychological assessment
64. Somatization in the community
65. Chemical sensitivity: The scientific literature
66. Neuropsychology and psychology of MCS
67. A controlled comparison of multiple chemical sensitivity and chronic fatigue syndrome
68. Evaluation of chemically sensitive patients
69. Assessment of neuropsychological function
70. The somatizing disorders
71. Somatization and fashionable diagnoses: Illness as a way of life
72. Multiple chemical sensitivity and environmental toxicology
73. Biochemical abnormalities in patients with multiple chemical sensitivities
74. Psychiatric and psychological aspects of fibromyalgia syndrome
75. A preliminary neuropsychological study of Persian Gulf veterans
76. The environmental somatization syndrome
77. Multiple chemical sensitivities: A symposium on the state of the science
78. Behavioral treatment of phobic avoidance in multiple chemical sensitivity
79. Multiple chemical sensitivity syndrome and porphyria: A note of caution and concern
80. Successful management of patients with 'multiple chemical sensitivities' on an inpatient psychiatric unit
81. Diagnostic markers of multiple chemical sensitivity
82. Multiple chemical sensitivity
83. The psychology of multiple allergy
84. Intranasal chemoreception in patients with multiple chemical sensitivities: A double-blind investigation
85. Conclusions and recommendations of a workshop on multiple chemical sensitivities (MCS)
86. Use and abuse of laboratory tests in clinical immunology: Critical considerations of eight widely used diagnostic procedures
87. Diagnosis and treatment of hypersensitivity syndrome
88. Research strategies for investigating multiple chemical sensitivity
89. Clinical ecology: Environmental medicine or unsubstantiated theory?
90. Laboratory testing of the patient with multiple chemical sensitivity
91. Somatization: Theories and research
92. Symptoms, syndrome, and semantics: Multiple chemical sensitivity and chronic fatigue syndrome
93. Immunological evaluation of chemically sensitive patients
94. Psychological treatment for atypical non-cardiac chest pain: A controlled evaluation
95. Performance, mood, and health during exposure to intermittent odors
96. Perceived odor intensity and hedonics in subjects with multiple chemical sensitivity
97. Manipulation of perception in mass tort litigation
98. Neurobehavioral assessment in toxic injury evaluations
99. Biases in perception and reporting following a perceived toxic exposure
100. Neurotoxicity of chronic low-dose exposure to organic solvents: A skeptical review
101. Response bias in self-reported history of plaintiffs compared with nonlitigating patients
102. Response bias in plaintiff's histories
103. Psychophysiological hypotheses regarding multiple chemical sensitivity syndrome
104. Report of multiple chemical sensitivities workshop, Berlin, Germany, 21-23 February 1996. PCS/96.29 IPCS, Geneva, Switzerland
105. Environmental illness: A disorder of immune regulation
106. Multiple chemical sensitivities: A practicing clinician's point of view. Clinical and immunologic research findings
107. Oxidants/anti-oxidants and chemical hypersensitivities (Part one)
108. Oxidants/anti-oxidants and chemical hypersensitivities (Part two)
109. Biochemical-pathology initiated by free radicals, oxidant chemicals, and therapeutic drugs in the etiology of chemical hypersensitivity disease
110. Clinical features of multiple chemical sensitivity
111. Provocative challenges in patients with multiple chemical sensitivity
112. Reply
113. Multiple chemical sensitivity: An emerging area of trial law
114. Sick building syndrome
115. Evolving concepts of chemical sensitivity
116. Multiple chemical sensitivity syndrome
117. Hyperventilation syndromes: Infrequently recognized common expressions of anxiety and stress
118. Somatoform disorders
119. Clinical uses of the WAIS-R: Base rate differences between VIQ and PIQ in the WAIS-R standardization sample
120. Food and chemical sensitivities. Clinical and immunologic correlates
121. Biological interventions in the treatment of patients with multiple chemical sensitivities
122. Immunological mechanisms of disease and the multiple chemical sensitivity syndrome
123. Neurogenic inflammation and sensitivity to environmental chemicals
124. Neurogenic switching: A hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity
125. Hypothesis for induction and propagation of chemical sensitivity based on biopsy studies
126. Psychogenic versus biologic basis for chemical sensitivity
127. Rhinolaryngoscopic examination of patients with the multiple chemical sensitivity syndrome
128. Possible models for multiple chemical sensitivity: Conceptual issues and role of the limbic system
129. White paper: Chemical sensitivity: History and phenomenology
130. Toxicant-induced loss of tolerance: An emerging theory of disease?
131. Allergy and multiple chemical sensitivities distinguished
132. Empirical approaches for the investigation of toxicant-induced loss of tolerance
133. Chemical sensitivity attributed to pesticide exposure versus remodeling
134. The epidemiology of multiple chemical sensitivities
135. Redefinition of abnormal susceptibility to environmental chemicals
136. On the dual nature of learning: A reinterpretation of 'conditioning' and 'problem-solving'
137. Behaviour therapy of hysterical disorders
138. Use of biologic markers in controversial areas of environmental health
139. Multiple chemical sensitivities syndrome: Toward a working case definition
140. Indoor air quality and personal factors related to the sick building syndrome
141. Psychological bases of symptom reporting: Perceptual and emotional aspects of chemical sensitivity
142. Guidelines for neuropsychological research in multiple sclerosis
143. The effects of behavioural treatment on chronic pain
144. Human and animal studies of cocaine: Implications for the development of behavioral pathology
145. Conditioning, sensitization, and kindling: Implications for the course of affective illness
146. Sensitization and kindling: Implications for the evolving neural substrates of posttraumatic stress disorder
147. Allergic-type reactions to industrial solvents and liquid fuels; mosquito abatement fogs and mists; motor exhausts; indoor utility gas and oil fumes; chemical additives of foods and drugs; and synthetic drugs and cosmetics
148. Depressions caused by home exposure to gas and combustion products of gas, oil, and coal
149. The specific adaptation syndrome
150. Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns, and prediction
151. Food and chemical susceptibility after environmental chemical overexposure: Case histories
152. Considerations for the diagnosis of chemical sensitivity
153. T and B lymphocyte parameters measures in chemically sensitive patients and controls
154. Confirmation of chemical sensitivity by means of double-blind inhalant challenge of toxic volatile chemicals
155. A survey of AOEC physician practices and attitudes regarding multiple chemical sensitivity
156. Multiple chemical sensitivity: Respect the observations...suspect the interpretations?
157. Clinical utility of immunologic tests
158. The NIMH Diagnostic Interview Schedule: Its history, characteristics, and validity
159. History and clinical presentation of the chemically sensitive patient
160. Treatment options in multiple chemical sensitivity
161. Clinical characteristics of chemical sensitivity: An illustrative case history of asthma and MCS
162. Integrated defense system overlap as a disease model: With examples for multiple chemical sensitivity
163. Dysfunctional buildings or dysfunctional people: An examination of the sick building syndrome and allied disorders
164. The impact of allergy and immunology on our expanding industrial environment
165. Clinical and immunological approach to patients with alleged environmental injury
166. Understanding clinical immunological testing in alleged chemically induced environmental illness
167. Multiple chemical sensitivity, multiorgan dysthesia, multiple symptom complex, and multiple confusion: Problems in diagnosing the patient presenting with unexplained multisystemic symptoms
168. Memory deficits associated with chronic fatigue immune dysfunction syndrome
169. Workers with multiple chemical sensitivities: A psychiatric approach to diagnosis and treatment
170. Occupation-induced post-traumatic stress disorders
171. Recognition of occupation-induced posttraumatic stress disorders
172. Psychological factors complicating the diagnosis of work-related chemical illness
173. Neuropsychophysiologic observations in patients presenting with environmental illness
174. Invited review: The psychological treatment of patients with functional somatic syndromes: A practical guide
175. Multiple chemical sensitivity: Pseudodisease in historical perspective
176. Behavioral sensitization to irritants/odorants after acute overexposures
177. Pavlovian conditioning and multiple chemical sensitivity
178. The question of multiple chemical sensitivity
179. Psychiatric treatments in multiple chemical sensitivity
180. Psychiatric symptoms in multiple chemical sensitivity
181. Questions and answers 3
182. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity
183. Intimidation of researchers by special-interest groups
184. Allergic to life: Psychological factors in environmental illness
185. The sick building syndrome
186. Influence of personal characteristics, job-related factors and psychosocial factors on the sick building syndrome
187. The relationship between fibromyalgia and the multiple chemical sensitivity syndrome
188. Neuroanatomy and neurochemical mechanisms of time-dependent sensitization
189. Potential role of stress and sensitization in the development and expression of multiple chemical sensitivity
190. Repeated low-level formaldehyde exposure produces cross-sensitization to cocaine: Possible relevance to chemical sensitivity in humans
191. Multiple chemical sensitivity syndrome: A clinical perspective. I. Case definition, theories of pathogenesis, and research needs
192. Multiple chemical sensitivity syndrome: A clinical perspective. II. Evaluation, diagnostic testing, treatment, and social considerations
193. The concept of an environmental unit
194. A structured interview for DSM-III personality disorder
195. Multiple chemical sensitivities or idiopathic environmental intolerances: Psychophysiologic foundation of knowledge for a psychogenic explanation
196. Neuropsychophysiology during relaxation in generalized, universal 'allergic' reactivity to the environment: A comparison study
197. Failure to assess psychopathology in patients presenting with chemical sensitivities
198. Double-blind provocation chamber challenges in 20 patients presenting with 'multiple chemical sensitivity'
199. Multiple chemical sensitivity
200. Environmental hypersensitivity disorder, total allergy and 20th century disease: A critical review
201. Emotional disorders misdiagnosed as physical illness: Environmental hypersensitivity, candidiasis hypersensitivity, and chronic fatigue syndrome
202. The changing faces of somatization
203. Psychiatric assessment of patients with '20th-century disease' ('total allergy syndrome')
204. Environmental illness: A clinical review of 50 cases
205. 'Multiple chemical sensitivities': Immunologic critique of clinical ecology theories and practice
206. Clinical ecology in the workplace
207. Immunological issues in 'multiple chemical sensitivities'
208. A critical analysis of multiple chemical sensitivities
209. Multiple chemical sensitivity: Controlled scientific studies as proof of causation
210. Learning to have psychosomatic complaints: Conditioning of respiratory behavior and somatic complaints in psychosomatic patients
211. The science of toxicology and its relevance to MCS
212. The fibromyalgia syndrome
213. Experimental strategies for research on multiple chemical sensitivity
214. Neurobehavioral properties of chemical sensitivity syndromes
215. Caveats in the use of the kindling model of affective disorders
216. Perceived toxic exposure: A review of four cognitive influences on perception of illness
217. Human response to traumatic events: An integration of counterfactual thinking, hindsight bias, and attributional theory
218. The prevalence of reactions to food additives in a survey population
219. Profile of patients with chemical injury and sensitivity
220. Multiple chemical sensitivity: Treatment and follow-up with avoidance and control of chemical exposures